<qa>  What is the overall survival of patients with unresectable stage III or stage IV melI. To compare the overall survival of patients with unresectable stage III or stage IV melanoma treated with carboplatin, paclitaxel and placebo versus carboplatin, paclitaxel and sorafenib sorafenib tosylate. 